多模式聚类揭示了结直肠癌存活率的无事件患者亚组
Nikita Janakarajan1,2, Guillaume Larghero3, María Rodríguez Martínez4
1IBM Research Europe, Rüschlikon, Switzerland. nja@zurich.ibm.com.
NPJ systems biology and applications
|August 2, 2025
概括
多omics数据改善了结直肠癌 (CRC) 患者存活率分层. 这项研究通过针对性特征选择和无监督聚类确定了一个新的无事件子组,从而推进了CRC的精密医学.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 结肠直肠癌 (CRC) 患者分层对于有效治疗和生存预测至关重要.
- 目前使用单模数据或共识分子亚型的分层方法在捕捉复杂的患者异质性方面存在局限性.
研究的目的:
- 为结直肠癌 (CRC) 制定一个基于多种OMIC的患者分层策略.
- 识别具有独特的生存结果的新型患者子组,传统方法无法检测到.
- 为了支持CRC的多omics驱动精密医学的进步.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库进行多omics方法.
- 雇佣有针对性的特征选择和无监督的集群用于患者分层.
- 进行了对变异的分析和基因组丰富分析,以获得生物学见解.
- 对已识别的患者集群进行了临床表征.
主要成果:
- 成功分层结直肠癌 (CRC) 患者基于使用多omics数据的疾病特异性生存率.
- 通过单模数据分析或现有的分子亚型无法辨别的独特无事件患者亚组.
- 发现了与不同患者集群相关的显著生物途径和临床特征.
结论:
- 与单模方法相比,多模数据为结直肠癌 (CRC) 患者分层提供了更强大的框架.
- 识别的无事件子组代表了一个潜在的独特的临床实体,需要进一步调查.
- 这些发现突显了多种OMIC集成的潜力,以推进结直肠癌 (CRC) 中的精准医学策略.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
194
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.6K
相关概念视频
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
01:20Comparing the Survival Analysis of Two or More Groups
287
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
287
01:24Kaplan-Meier Approach
266
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
266